A Randomized Prospective Study Comparing Long-Term Intravesical Instillations of Mitomycin C and Bacillus Calmette-Guerin in Patients with Superficial Bladder Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Randomized Prospective Study Comparing Long-Term Intravesical Instillations of Mitomycin C and Bacillus Calmette-Guerin in Patients with Superficial Bladder Carcinoma

Published:1996-08 Issue:2 Volume:156 Page:372-376
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Lundholm Carl,Norlen Bo Johan,Ekman Peter,Jahnson Staffan,Lagerkvist Mikael,Lindeborg Torsten,Olsson Jan Olov,Tveter Kjell Wijkstrom,Westberg Ronny,Malmstrom Per-Uno

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non–muscle-invasive bladder cancer: A network meta-analysis;Urologic Oncology: Seminars and Original Investigations;2023-06

2. Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette–Guérin instillation in non-muscle-invasive bladder cancer: a network meta-analysis;Frontiers in Oncology;2023-05-12

3. Floating poly(lactic-co-glycolic acid)-based controlled-release drug delivery system for intravesical instillation;Journal of International Medical Research;2023-04

4. Role of Intravesical BCG as a Therapeutic Vaccine for Treatment of Bladder Carcinoma;Iranian Biomedical Journal;2022-10-01

5. Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition);Military Medical Research;2022-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP